← Back to Search

Behavioural Intervention

Resistance Training for Type 2 Diabetes

N/A
Waitlist Available
Led By Flavio De Castro Magalhaes, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Living with type 2 diabetes mellitus
Be older than 18 years old
Must not have
Have acute myocarditis, endocarditis, or pericarditis
Have uncontrolled hypertension (>160 mmHg systolic and/or >100 mmHg diastolic)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up for 60 hours before the first training session and for 60 hours after the last (32nd) training session
Awards & highlights

Summary

This trial aims to study how different levels of resistance exercise affect blood sugar control and mental well-being in people with type 2 diabetes. Additionally, the study will look at how many participants stick to the

Who is the study for?
This trial is for individuals with type 2 diabetes who are interested in how different levels of effort during resistance exercise training can affect their blood sugar control and mental well-being. Details on specific inclusion or exclusion criteria were not provided.
What is being tested?
The study compares the effects of high-effort versus low-effort resistance exercise training on managing blood sugar levels and improving mood in people with type 2 diabetes. It also looks at how likely participants are to stick with these exercise programs.
What are the potential side effects?
Specific side effects aren't listed, but generally, resistance training may cause muscle soreness, fatigue, or injury if not done correctly. Participants should follow instructions carefully to minimize risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have type 2 diabetes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have inflammation of the heart muscle, lining, or outer covering.
Select...
My blood pressure is not higher than 160/100 mmHg.
Select...
My heart condition is not stable.
Select...
I have had serious heart problems.
Select...
My heart is unable to pump blood effectively.
Select...
I have irregular heartbeats that aren't well-managed.
Select...
I cannot walk by myself.
Select...
I have an aortic aneurysm that has not been surgically repaired.
Select...
I have had an amputation of a part of my lower limb.
Select...
I have kidney failure.
Select...
I have liver disease.
Select...
I have severe pulmonary hypertension.
Select...
I have severe aortic stenosis causing symptoms.
Select...
I have an aortic dissection.
Select...
I have a severe form of diabetic eye disease.
Select...
I have taken medication in the past 6 months that could affect my tendons.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~for 60 hours before the first training session and for 60 hours after the last (32nd) training session
This trial's timeline: 3 weeks for screening, Varies for treatment, and for 60 hours before the first training session and for 60 hours after the last (32nd) training session for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Glucose concentration
Secondary study objectives
Adherence to the resistance training protocols

Trial Design

2Treatment groups
Experimental Treatment
Group I: Low-effortExperimental Treatment1 Intervention
The low-effort protocol will entail performing 6 sets per exercise, 4 repetitions per set, \~2.5 seconds per repetition, with 60 seconds between sets and exercises.
Group II: High-effortExperimental Treatment1 Intervention
The high-effort protocol will entail performing 3 sets per exercise, 8 repetitions per set, \~2.5 seconds per repetition, with 120 seconds between sets and exercises.

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
383 Previous Clinical Trials
3,523,146 Total Patients Enrolled
Flavio De Castro Magalhaes, PhDPrincipal InvestigatorAssistant Professor
1 Previous Clinical Trials
15 Total Patients Enrolled
~32 spots leftby Dec 2025